product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human SCF Protein, CF
catalog :
255-SC-010/CF
quantity :
10 ug (also 50 ug, 200 ug, 1 mg)
price :
219 USD
more info or order :
citations: 156
Reference
Sahoo S, Pastor V, Goodings C, Voss R, Kozyra E, Szvetnik A, et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med. 2021;27:1806-1817 pubmed publisher
Yu S, Di C, Chen S, Guo M, Yan J, Zhu Z, et al. Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects. Cell Res. 2021;31:1148-1162 pubmed publisher
Schwartz G, Kubo H, Laronda M. Generation of two human induced pluripotent stem cell lines from a patient with complete androgen insensitivity syndrome with a hemizygous single nucleotide variant in the androgen receptor (AR) gene. Stem Cell Res. 2021;55:102441 pubmed publisher
Kato H, Maezawa Y, Ouchi Y, Takayama N, Sone M, Sone K, et al. Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome. Stem Cell Res. 2021;53:102360 pubmed publisher
Newby G, Yen J, Woodard K, Mayuranathan T, Lazzarotto C, Li Y, et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature. 2021;595:295-302 pubmed publisher
Reid J, Golubeva D, Boyd A, Hollands C, Henly C, Orlando L, et al. Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patients. Cell Rep. 2021;34:108845 pubmed publisher
Yuan W, Yao Z, Veerapandian V, Yang X, Wang X, Chen D, et al. The histone demethylase KDM2B regulates human primordial germ cell-like cells specification. Int J Biol Sci. 2021;17:527-538 pubmed publisher
Hwang Y, Suzuki S, Seita Y, Ito J, Sakata Y, Aso H, et al. Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells. Nat Commun. 2020;11:5656 pubmed publisher
Wesely J, Kotini A, Izzo F, Luo H, Yuan H, Sun J, et al. Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells. Cell Rep. 2020;31:107688 pubmed publisher
Norbnop P, Ingrungruanglert P, Israsena N, Suphapeetiporn K, Shotelersuk V. Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells. Sci Rep. 2020;10:8472 pubmed publisher
Demirci S, Gudmundsdottir B, Li Q, Haro Mora J, Nassehi T, Drysdale C, et al. βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells. Mol Ther Methods Clin Dev. 2020;17:912-921 pubmed publisher
Yamashiro C, Sasaki K, Yokobayashi S, Kojima Y, Saitou M. Generation of human oogonia from induced pluripotent stem cells in culture. Nat Protoc. 2020;15:1560-1583 pubmed publisher
Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
Leonard A, Yapundich M, Nassehi T, Gamer J, Drysdale C, Haro Mora J, et al. Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice. Mol Ther Methods Clin Dev. 2019;15:430-437 pubmed publisher
Li Z, Fang F, Zhao Q, Li H, Xiong C. Supplementation of vitamin C promotes early germ cell specification from human embryonic stem cells. Stem Cell Res Ther. 2019;10:324 pubmed publisher
Ruiz J, Chen G, Haro Mora J, Keyvanfar K, Liu C, Zou J, et al. Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system. Stem Cell Res. 2019;41:101600 pubmed publisher
Ikuno T, Ito S, Inoue T. Human induced pluripotent stem cell-derived mast cells useful for in vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells. J Toxicol Sci. 2019;44:789-797 pubmed publisher
Chagraoui J, Lehnertz B, Girard S, Spinella J, Fares I, Tomellini E, et al. UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal. PLoS ONE. 2019;14:e0224900 pubmed publisher
Grajcarek J, Monlong J, Nishinaka Arai Y, Nakamura M, Nagai M, Matsuo S, et al. Genome-wide microhomologies enable precise template-free editing of biologically relevant deletion mutations. Nat Commun. 2019;10:4856 pubmed publisher
Proto W, Siegel S, Dankwa S, Liu W, Kemp A, Marsden S, et al. Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand. Nat Commun. 2019;10:4512 pubmed publisher
Uchida N, Hsieh M, Raines L, Haro Mora J, Demirci S, Bonifacino A, et al. Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders. Nat Commun. 2019;10:4479 pubmed publisher
Rogers G, Chen H, Morales H, Cannon P. Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break. Mol Ther. 2019;27:1726-1736 pubmed publisher
Ly M, Rentas S, Vujovic A, Wong N, Moreira S, Xu J, et al. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance. Cancer Res. 2019;79:5799-5811 pubmed publisher
McKenzie M, Ghisi M, Oxley E, Ngo S, Cimmino L, Esnault C, et al. Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia. Cell Stem Cell. 2019;25:258-272.e9 pubmed publisher
Kinney M, Vo L, Frame J, Barragan J, Conway A, Li S, et al. A systems biology pipeline identifies regulatory networks for stem cell engineering. Nat Biotechnol. 2019;37:810-818 pubmed publisher
Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed publisher
Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019;27:599-615.e12 pubmed publisher
Tobío A, Bandara G, Morris D, Kim D, O Connell M, Komarow H, et al. Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production. Haematologica. 2019;: pubmed publisher
Seneviratne A, Xu M, Henao J, Fajardo V, Hao Z, Voisin V, et al. The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids. Cell Stem Cell. 2019;24:621-636.e16 pubmed publisher
Hochdörfer T, Winkler C, Pardali K, Mjösberg J. Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells. Eur J Immunol. 2019;49:884-893 pubmed publisher
Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, et al. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Cell Stem Cell. 2019;: pubmed publisher
Suga M, Kondo T, Imamura K, Shibukawa R, Okanishi Y, Sagara Y, et al. Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I. Stem Cell Res. 2019;36:101406 pubmed publisher
Uchida N, Nassehi T, Drysdale C, Gamer J, Yapundich M, Demirci S, et al. High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2. Mol Ther Methods Clin Dev. 2019;13:187-196 pubmed publisher
Wang X, Liao T, Wan C, Yang X, Zhao J, Fu R, et al. Efficient generation of human primordial germ cell-like cells from pluripotent stem cells in a methylcellulose-based 3D system at large scale. Peerj. 2019;6:e6143 pubmed publisher
Potirat P, Wattanapanitch M, Viprakasit V, Kheolamai P, Issaragrisil S. An integration-free iPSC line (MUSIi008-A) derived from a patient with severe hemolytic anemia carrying compound heterozygote mutations in KLF1 gene for disease modeling. Stem Cell Res. 2019;34:101344 pubmed publisher
Poldee S, Metheetrairut C, Nugoolsuksiri S, Frayne J, Trakarnsanga K. Optimization of an erythroid culture system to reduce the cost of in vitro production of red blood cells. MethodsX. 2018;5:1626-1632 pubmed publisher
Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, et al. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy. Cell Stem Cell. 2018;23:850-858.e4 pubmed publisher
Camgoz A, Paszkowski Rogacz M, Satpathy S, Wermke M, Hamann M, von Bonin M, et al. STK3 is a therapeutic target for a subset of acute myeloid leukemias. Oncotarget. 2018;9:25458-25473 pubmed publisher
Ueda N, Uemura Y, Zhang R, Kitayama S, Iriguchi S, Kawai Y, et al. Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response. Stem Cell Reports. 2018;: pubmed publisher
Shen P, Yang S, Sun H, Li G, Wu B, Ji F, et al. SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma. Int J Mol Sci. 2018;19: pubmed publisher
Allenby M, Tahlawi A, Morais J, Li K, Panoskaltsis N, Mantalaris A. Ceramic Hollow Fibre Constructs for Continuous Perfusion and Cell Harvest from 3D Hematopoietic Organoids. Stem Cells Int. 2018;2018:6230214 pubmed publisher
Cesana M, Guo M, Cacchiarelli D, Wahlster L, Barragan J, Doulatov S, et al. A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. Cell Stem Cell. 2018;22:575-588.e7 pubmed publisher
Kotha S, Sun S, Adams A, Hayes B, Phong K, NAGAO R, et al. Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment. PLoS ONE. 2018;13:e0195082 pubmed publisher
Han S, Lee E, Choi H, Chun B, Baek E. The effects of plasma gelsolin on human erythroblast maturation for erythrocyte production. Stem Cell Res. 2018;29:64-75 pubmed publisher
Ferrer C, Alders M, Postma A, Park S, Klein M, Cetinbaş M, et al. An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality. Genes Dev. 2018;32:373-388 pubmed publisher
Zheng S, Papalexi E, Butler A, STEPHENSON W, Satija R. Molecular transitions in early progenitors during human cord blood hematopoiesis. Mol Syst Biol. 2018;14:e8041 pubmed publisher
Schmitt K, Charlins P, Veselinovic M, Kinner Bibeau L, Hu S, Curlin J, et al. Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model. Virology. 2018;515:235-242 pubmed publisher
Carretta M, Brouwers Vos A, Bosman M, Horton S, Martens J, Vellenga E, et al. BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells. PLoS ONE. 2017;12:e0189102 pubmed publisher
Bar Ephraim Y, Cornelissen F, Papazian N, Konijn T, Hoogenboezem R, Sanders M, et al. Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation. Cell Rep. 2017;21:823-833 pubmed publisher
Radecke S, Schwarz K, Radecke F. Genome-wide Mapping of Off-Target Events in Single-Stranded Oligodeoxynucleotide-Mediated Gene Repair Experiments. Mol Ther. 2018;26:115-131 pubmed publisher
Palpant N, Wang Y, Hadland B, Zaunbrecher R, Redd M, Jones D, et al. Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis. Cell Rep. 2017;20:1597-1608 pubmed publisher
Butcher L, Ahluwalia M, Ord T, Johnston J, Morris R, Kiss Toth E, et al. Evidence for a role of TRIB3 in the regulation of megakaryocytopoiesis. Sci Rep. 2017;7:6684 pubmed publisher
Helft J, Anjos Afonso F, van der Veen A, Chakravarty P, Bonnet D, Reis E Sousa C. Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors. Cell Rep. 2017;20:529-537 pubmed publisher
Varga E, Nemes C, Bock I, Táncos Z, Berzsenyi S, Lévay G, et al. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD). Stem Cell Res. 2017;21:19-22 pubmed publisher
Huang J, Khan A, Au B, Barber D, Lopez Vasquez L, Prokopishyn N, et al. Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease. Mol Ther Methods Clin Dev. 2017;5:241-258 pubmed publisher
Jeong W, Jung S, Bazer F, Kim J. Stem cell factor-induced AKT cell signaling pathway: Effects on porcine trophectoderm and uterine luminal epithelial cells. Gen Comp Endocrinol. 2017;250:113-121 pubmed publisher
Zhao H, Gulesserian S, Malinao M, Ganesan S, Song J, Chang M, et al. A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise. Mol Cancer Ther. 2017;16:1866-1876 pubmed publisher
Liu S, Ye Z, Gao Y, He C, Williams D, MOLITERNO A, et al. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene. Stem Cell Res. 2017;18:57-59 pubmed publisher
Trakarnsanga K, Griffiths R, Wilson M, Blair A, Satchwell T, Meinders M, et al. An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat Commun. 2017;8:14750 pubmed publisher
Kotini A, Chang C, Chow A, Yuan H, Ho T, Wang T, et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell. 2017;20:315-328.e7 pubmed publisher
Baccelli I, Krosl J, Boucher G, Boivin I, Lavallée V, Hébert J, et al. A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens. Blood Cancer J. 2017;7:e529 pubmed publisher
Garton A, Seibel S, Lopresti Morrow L, Crew L, Janson N, Mandiyan S, et al. Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression. Mol Cancer Ther. 2017;16:671-680 pubmed publisher
Cárcamo Orive I, Hoffman G, Cundiff P, Beckmann N, D Souza S, Knowles J, et al. Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. Cell Stem Cell. 2017;20:518-532.e9 pubmed publisher
Nakagawa N, Barron L, Gomez I, Johnson B, Roach A, Kameoka S, et al. Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight. 2016;1:e87446 pubmed publisher
Huang J, Liu Y, Au B, Barber D, Arruda A, Schambach A, et al. Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML. Mol Ther Methods Clin Dev. 2016;3:16074 pubmed
Stratman A, Pezoa S, Farrelly O, Castranova D, Dye L, Butler M, et al. Interactions between mural cells and endothelial cells stabilize the developing zebrafish dorsal aorta. Development. 2017;144:115-127 pubmed publisher
Rabinovich E, Heyne M, Bakhman A, Kosloff M, Shifman J, Papo N. Identifying Residues that Determine SCF Molecular-Level Interactions through a Combination of Experimental and In silico Analyses. J Mol Biol. 2017;429:97-114 pubmed publisher
Schrimpf C, Wrede C, Glage S, Hegermann J, Backhaus S, Blasczyk R, et al. Differentiation of induced pluripotent stem cell-derived neutrophil granulocytes from common marmoset monkey (Callithrix jacchus). Transfusion. 2017;57:60-69 pubmed publisher
Pantin J, Purev E, Tian X, Cook L, Donohue Jerussi T, Cho E, et al. Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial. Haematologica. 2017;102:600-609 pubmed publisher
Bhatt N, Ghosh R, Roy S, Gao Y, Armanios M, Cheng L, et al. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells. Stem Cell Res. 2016;17:296-305 pubmed publisher
Kim H, Lee J, Heo H, Yang S, Ha K, Park W, et al. Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway. Cell Biosci. 2016;6:50 pubmed publisher
Tsuzuki H, Arinobu Y, Miyawaki K, Takaki A, Ota S, Ota Y, et al. Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes. Immunology. 2017;150:64-73 pubmed publisher
Yamada D, Iyoda T, Vizcardo R, Shimizu K, Sato Y, Endo T, et al. Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo. Stem Cells. 2016;34:2852-2860 pubmed publisher
Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed publisher
Vasu S, He S, Cheney C, Gopalakrishnan B, Mani R, Lozanski G, et al. Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts. Blood. 2016;127:2879-89 pubmed publisher
Hermanson D, Bendzick L, Pribyl L, McCullar V, Vogel R, Miller J, et al. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells. 2016;34:93-101 pubmed publisher
Kitajima K, Nakajima M, Kanokoda M, Kyba M, Dandapat A, Tolar J, et al. GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells. Exp Hematol. 2016;44:68-74.e1-10 pubmed publisher
Breton G, Lee J, Liu K, Nussenzweig M. Defining human dendritic cell progenitors by multiparametric flow cytometry. Nat Protoc. 2015;10:1407-22 pubmed publisher
Jiang X, Lim C, Li Z, Lee P, Yatim S, Guan P, et al. Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML). PLoS ONE. 2015;10:e0122983 pubmed publisher
Patterson S, Rossi J, Paweletz K, Fitzpatrick V, Begley C, Busse L, et al. Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues. PLoS ONE. 2015;10:e0122149 pubmed publisher
Lamikanra A, Merryweather Clarke A, Tipping A, Roberts D. Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment. PLoS ONE. 2015;10:e0119836 pubmed publisher
Lee J, Graham M, Collins T, Lee J, Hong S, Mcnicol A, et al. Reversible lineage-specific priming of human embryonic stem cells can be exploited to optimize the yield of differentiated cells. Stem Cells. 2015;33:1142-52 pubmed publisher
Purushothaman P, Thakker S, Verma S. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells. J Virol. 2015;89:3093-111 pubmed publisher
Kim H, Yun J, Shin T, Lee S, Lee B, Yu K, et al. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation. Stem Cells. 2015;33:1254-66 pubmed publisher
Song B, Fan Y, He W, Zhu D, Niu X, Wang D, et al. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system. Stem Cells Dev. 2015;24:1053-65 pubmed publisher
Barese C, Felizardo T, Sellers S, Keyvanfar K, Di Stasi A, Metzger M, et al. Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques. Stem Cells. 2015;33:91-100 pubmed publisher
Shen S, Xu N, Klamer G, Ko K, Khoo M, Ma D, et al. Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice. Stem Cells Dev. 2015;24:724-36 pubmed publisher
Kazuki Y, Yakura Y, Abe S, Osaki M, Kajitani N, Kazuki K, et al. Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies. Sci Rep. 2014;4:6136 pubmed publisher
Dighe N, Khoury M, Mattar C, Chong M, Choolani M, Chen J, et al. Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector. PLoS ONE. 2014;9:e104805 pubmed publisher
Rosen D, Leung L, Louie B, Cordeiro J, Conroy A, Shapira I, et al. Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP). J Transl Med. 2014;12:184 pubmed publisher
Smith L, Ul Hasan T, Carvaines S, Van Vliet K, Yang E, WONG K, et al. Gene transfer properties and structural modeling of human stem cell-derived AAV. Mol Ther. 2014;22:1625-34 pubmed publisher
Horwitz M, Chao N, Rizzieri D, Long G, Sullivan K, Gasparetto C, et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest. 2014;124:3121-8 pubmed publisher
Khoo M, Carlin S, Lutherborrow M, Jayaswal V, Ma D, Moore J. Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells. Aging Cell. 2014;13:744-54 pubmed publisher
Jitkova Y, Gronda M, Hurren R, Wang X, Goard C, Jhas B, et al. A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity. PLoS ONE. 2014;9:e95281 pubmed publisher
Muench M, Beyer A, Fomin M, Thakker R, Mulvaney U, Nakamura M, et al. The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny. PLoS ONE. 2014;9:e97312 pubmed publisher
Chaurasia P, Gajzer D, Schaniel C, D Souza S, Hoffman R. Epigenetic reprogramming induces the expansion of cord blood stem cells. J Clin Invest. 2014;124:2378-95 pubmed publisher
Wu C, Li B, Lu R, Koelle S, Yang Y, Jares A, et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell. 2014;14:486-499 pubmed publisher
Williams M, Yousafzai Y, Cox C, Blair A, Carmody R, Sai S, et al. Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood. 2014;123:3116-27 pubmed publisher
Levescot A, Flamant S, Basbous S, Jacomet F, Feraud O, Anne Bourgeois E, et al. BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients. Cancer Res. 2014;74:2669-76 pubmed publisher
Vannucchi A, Rotunno G, Bartalucci N, Raugei G, Carrai V, Balliu M, et al. Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. Leukemia. 2014;28:1811-8 pubmed publisher
Reynolds C, Roderick J, LaBelle J, Bird G, Mathieu R, Bodaar K, et al. Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:1819-27 pubmed publisher
Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014;14:535-48 pubmed publisher
Jensen B, Frandsen P, Raaby E, Schiøtz P, Skov P, Poulsen L. Molecular and stimulus-response profiles illustrate heterogeneity between peripheral and cord blood-derived human mast cells. J Leukoc Biol. 2014;95:893-901 pubmed publisher
Kamat V, Paluru P, Myint M, French D, Gadue P, Diamond S. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells. 2014;32:1337-46 pubmed publisher
Smith A, Bowers S, Stratman A, Davis G. Hematopoietic stem cell cytokines and fibroblast growth factor-2 stimulate human endothelial cell-pericyte tube co-assembly in 3D fibrin matrices under serum-free defined conditions. PLoS ONE. 2013;8:e85147 pubmed publisher
Klimenkova O, Ellerbeck W, Klimiankou M, Unalan M, Kandabarau S, Gigina A, et al. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood. 2014;123:1239-49 pubmed publisher
Tolar J, McGrath J, Xia L, Riddle M, Lees C, Eide C, et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2014;134:1246-1254 pubmed publisher
Sjeklocha L, Wong P, Belcher J, Vercellotti G, Steer C. ?-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model. PLoS ONE. 2013;8:e80403 pubmed publisher
Uchida N, Weitzel R, Evans M, Green R, Bonifacino A, Krouse A, et al. Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model. Gene Ther. 2014;21:148-57 pubmed publisher
Csaszar E, Wang W, Usenko T, Qiao W, Delaney C, Bernstein I, et al. Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood. 2014;123:650-8 pubmed publisher
Doulatov S, Vo L, Chou S, Kim P, Arora N, Li H, et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell. 2013;13:459-70 pubmed publisher
Morishima T, Watanabe K, Niwa A, Hirai H, Saida S, Tanaka T, et al. Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis. Haematologica. 2014;99:19-27 pubmed publisher
Bachet J, Tabone Eglinger S, Dessaux S, Besse A, Brahimi Adouane S, Emile J, et al. Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples. PLoS ONE. 2013;8:e61103 pubmed publisher
Yu J, Peng Y, Wu L, Xie Z, Deng Y, Hughes T, et al. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS ONE. 2013;8:e55934 pubmed publisher
Farrer R, Farrer J, DeVries G. Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14. J Biol Chem. 2013;288:11066-73 pubmed publisher
Giannoni F, Hardee C, Wherley J, Gschweng E, Senadheera S, Kaufman M, et al. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells. Mol Ther. 2013;21:1044-54 pubmed publisher
Lee M, Prasain N, Chae H, Kim Y, Mantel C, Yoder M, et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells. 2013;31:666-81 pubmed publisher
Todd J, Scurr L, Becker T, Kefford R, Rizos H. The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma. Oncogene. 2014;33:236-45 pubmed publisher
Jawad M, Yu N, Seedhouse C, Tandon K, Russell N, Pallis M. Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia. BMC Cancer. 2012;12:431 pubmed publisher
Kobune M, Iyama S, Kikuchi S, Horiguchi H, Sato T, Murase K, et al. Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms. Blood Cancer J. 2012;2:e87 pubmed publisher
Li Q, Ramirez Bergeron D, Dunwoodie S, Yang Y. Cited2 gene controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4 gene. J Biol Chem. 2012;287:29088-100 pubmed publisher
Ichii M, Frank M, Iozzo R, Kincade P. The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood. 2012;119:1683-92 pubmed publisher
Silk K, Silk J, Ichiryu N, Davies T, Nolan K, Leishman A, et al. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. Gene Ther. 2012;19:1035-40 pubmed publisher
Torrano V, Procter J, Cardus P, Greaves M, Ford A. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood. 2011;118:4910-8 pubmed publisher
Niwa A, Heike T, Umeda K, Oshima K, Kato I, Sakai H, et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS ONE. 2011;6:e22261 pubmed publisher
Uchida N, Hsieh M, Hayakawa J, Madison C, Washington K, Tisdale J. Optimal conditions for lentiviral transduction of engrafting human CD34+ cells. Gene Ther. 2011;18:1078-86 pubmed publisher
Tolar J, Park I, Xia L, Lees C, Peacock B, Webber B, et al. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood. 2011;117:839-47 pubmed publisher
Kirouac D, Ito C, Csaszar E, Roch A, Yu M, Sykes E, et al. Dynamic interaction networks in a hierarchically organized tissue. Mol Syst Biol. 2010;6:417 pubmed publisher
Stratman A, Malotte K, Mahan R, Davis M, Davis G. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood. 2009;114:5091-101 pubmed publisher
Duraisingham S, Hornig J, Gotch F, Patterson S. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J Immunol. 2009;183:2242-51 pubmed publisher
Margulis A, Nocka K, Brennan A, Deng B, Fleming M, Goldman S, et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J Immunol. 2009;183:1739-50 pubmed publisher
Ye L, Chang J, Lin C, Sun X, Yu J, Kan Y. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A. 2009;106:9826-30 pubmed publisher
Aerbajinai W, Zhu J, Kumkhaek C, Chin K, Rodgers G. SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. Blood. 2009;114:187-94 pubmed publisher
Margulis A, Nocka K, Wood N, Wolf S, Goldman S, Kasaian M. MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice. Am J Physiol Lung Cell Mol Physiol. 2009;296:L236-47 pubmed publisher
Hollins F, Kaur D, Yang W, Cruse G, Saunders R, Sutcliffe A, et al. Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J Immunol. 2008;181:2772-80 pubmed
Kobune M, Kawano Y, Takahashi S, Takada K, Murase K, Iyama S, et al. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells. Exp Hematol. 2008;36:1121-31 pubmed publisher
Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol. 2008;36:1035-46 pubmed publisher
McCullar V, Oostendorp R, Panoskaltsis Mortari A, Yun G, Lutz C, Wagner J, et al. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. Exp Hematol. 2008;36:598-608 pubmed publisher
Gunetti M, Ferrero I, Rustichelli D, Berger M, Gammaitoni L, Timeus F, et al. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp Hematol. 2008;36:235-43 pubmed publisher
Bogatkevich G, Ludwicka Bradley A, Highland K, Hant F, Nietert P, Singleton C, et al. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum. 2007;56:2432-42 pubmed
Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, et al. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts. Stem Cells. 2007;25:1862-71 pubmed
Srivastava A, Nedelcu E, Esmaeli Azad B, Mishra R, Carrier E. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells. Stem Cells. 2007;25:1456-61 pubmed
Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, et al. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood. 2007;109:4264-71 pubmed
Hiroyama T, Miharada K, Aoki N, Fujioka T, Sudo K, Danjo I, et al. Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells. Exp Hematol. 2006;34:760-9 pubmed
Yu H, Fang D, Kumar S, Li L, Nguyen T, Acs G, et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 2006;168:1879-88 pubmed
Kahl C, Tarantal A, Lee C, Jimenez D, Choi C, Pepper K, et al. Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector. Exp Hematol. 2006;34:369-81 pubmed
Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, et al. Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells. Cell Death Differ. 2006;13:1686-96 pubmed
Hsieh F, Sharma P, Gibbons A, Goggans T, Erzurum S, Haque S. Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc Natl Acad Sci U S A. 2005;102:14380-5 pubmed
Hanley M, Napolitano L, McCune J. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells. 2005;23:1170-9 pubmed
Féménia F, Arock M, Leriche L, Delouis C, Millet G, Ben Hamouda N, et al. Establishment and characterization of continuous hematopoietic progenitors-derived pig normal mast cell lines. Life Sci. 2005;77:808-23 pubmed
Wang J, Roy S. Growth differentiation factor-9 and stem cell factor promote primordial follicle formation in the hamster: modulation by follicle-stimulating hormone. Biol Reprod. 2004;70:577-85 pubmed
Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
Da Silva C, Kassel O, Mathieu E, Massard G, Gasser B, Frossard N. Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF. Br J Pharmacol. 2002;135:1634-40 pubmed
Shih C, Hu M, Hu J, Weng Y, Yazaki P, Medeiros J, et al. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood. 2000;95:1957-66 pubmed
Gomez Navarro J, Contreras J, Arafat W, Jiang X, Krisky D, Oligino T, et al. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Ther. 2000;7:43-52 pubmed
Drouet M, Mathieu J, Grenier N, Multon E, Sotto J, Herodin F. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells. 1999;17:273-85 pubmed
image
image 1 :
R&D Systems 255-SC-010/CF image 1
Recombinant Human SCF Protein Bioactivity
product information
brand :
R&D Systems
master code :
255-SC/CF
SKU :
255-SC-010/CF
product name :
Recombinant Human SCF Protein, CF
description :
The SCF/c-kit Ligand Protein from 255-SC-010/CF is derived from E. coli-derived Recombinant Human SCF Protein. The SCF/c-kit Ligand Protein has been validated for the following applications: P21583.1.
target :
SCF/c-kit Ligand
category :
Proteins and Enzymes
unit sizes :
10 ug (also 50 ug, 200 ug, 1 mg)
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
17-18 kDa, under reducing condtitions
theoretical molecular weight :
19 kDa
gene symbol :
KITLG
details of functionality :
Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al . (1989) J. Cell Physiol. 140 :323. The ED50 for this effect is 1-5 ng/mL. The specific activity of Recombinant Human SCF is approximately 1.3 x 106 IU/mg, which is calibrated against recombinant human SCF WHO International Standard (NIBSC code: 91/682). Specific activity is for reference purposes only and is not routinely tested.
endotoxin note :
<1.0 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
P21583.1
applications :
Bioactivity
extended description :
A New rh SCF is Now Available! It has a lower endotoxin specification and is human cell expressed!
source :
E. coli-derived Recombinant Human SCF Protein
USD :
219 USD
product details :
A New rh SCF is Now Available! It has a lower endotoxin specification and is human cell expressed!
alt names :
c-kit Ligand, DCUA, DFNA69, DKFZp686F2250, familial progressive hyperpigmentation 2, FPH2, FPHH, KIT ligand, Kitl, KITLG, KL-1, Mast cell growth factor, MGF, MGFSHEP7, SCFStem cell factor, SFc-Kit ligand, SHEP7, SLF, steel factor
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.